Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Real-Time Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01336 NCI
RTNominal up32.100 +0.150 (+0.469%)

12/09/2019 18:01

{I-bank focus}Goldman downgrades NCI (01336) to HK$40

[ET Net News Agency, 12 September 2019] Goldman Sachs lowered its target price for New
China Life Insurance (NCI)(01336) to HK$40 from HK$49 and downgraded its rating to
"neutral" from "buy".
The research house said NCI is up 10% year-to-date, underperforming H-share peers (15%)
but outperforming the HSCEI index (4%). Goldman noted that this underperformance was
mostly after 1H results.
More importantly, it noted that NCI reported a decline in agent productivity and lower
margin, in both the agency and the bancassurance channels. These represent a significant
deviation from the previous focus on agent quality and protection-product sales.
Goldman reduced its 2019/20/21 NBV by 18%/22%/25% for NCI. It raised FY2019 earnings by
19% to reflect one-off tax refund in 1H and fine-tuned FY2020/21 earnings by +1%/+2%. (KL)

Remark: Real time quote last updated: 24/01/2020 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2020 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.